tiprankstipranks
Alignment Healthcare, Inc. (ALHC)
NASDAQ:ALHC
US Market
Want to see ALHC full AI Analyst Report?

Alignment Healthcare (ALHC) Earnings Dates, Call Summary & Reports

184 Followers

Earnings Data

Report Date
Jul 30, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.13
Last Year’s EPS
0.07
Same Quarter Last Year
Based on 9 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call highlights robust top-line growth (membership +31%, revenue +33%), strong margin expansion (adjusted EBITDA up 88%), improved efficiency (SG&A as % of revenue down ~60 bps) and strengthened liquidity, alongside tangible operational progress in automation and AI. The main negatives were a one-time internal workflow error that temporarily increased inpatient admissions and some short-term utilization pressure tied to targeting higher-acuity members, plus industry-level uncertainty from modest CMS rate increases versus underlying health care trend. Management portrayed these issues as diagnosed and remediated or baked into guidance, and raised full-year guidance and tightened ranges, indicating confidence in execution and outlook.
Company Guidance
Alignment's 2026 guidance: full-year membership 294,000–299,000, revenue $5.16B–$5.21B (midpoint ≈ $5.185B, ~31% YoY), adjusted gross profit $620M–$650M and adjusted EBITDA $138M–$163M (company raised the low end of adjusted gross profit and adjusted EBITDA by $5M each); Q2 guidance calls for membership 288,000–290,000, revenue $1.30B–$1.32B, adjusted gross profit $167M–$177M and adjusted EBITDA $50M–$60M. Management expects ~60% of full‑year EBITDA to be generated in the first half (vs ~55% in 1H‑2025) and is targeting first‑half year‑over‑year improvements of roughly 40 bps MBR, 40 bps SG&A and 90–100 bps EBITDA margin expansion, while assuming higher inpatient admissions per 1,000 (mix-related) and no new‑member final suite pickup in the outlook.
Strong Membership Growth
Health plan membership of 284,800 representing ~31% year-over-year growth, driving scale and supporting revenue expansion.
Revenue Expansion
Total revenue of $1.2 billion in Q1, up 33% year-over-year.
Margin and Profitability Improvement
Adjusted EBITDA of $38 million, up 88% year-over-year, implying an adjusted EBITDA margin of 3.1% and ~90 basis points of margin expansion versus prior year.
Adjusted Gross Profit and Medical Benefit Ratio (MBR)
Adjusted gross profit of $146 million with an adjusted MBR of 88.2%, an improvement of ~20 basis points year-over-year.
Operating Efficiency (SG&A)
Adjusted SG&A of $108 million (up 24% year-over-year in absolute dollars) but improved as a percentage of revenue to 8.7% from 9.4% (~60 basis points improvement), reflecting automation and scaling benefits.
Balance Sheet and Liquidity
Strong liquidity with $726 million in cash, cash equivalents and short-term investments; funded leverage improved to 2.6x trailing 12-month EBITDA.
Raised Full-Year Guidance and Confident Outlook
Full-year 2026 guidance raised: membership expected 294,000–299,000; revenue guidance $5.16B–$5.21B (midpoint implies ~31% YoY growth); adjusted gross profit and adjusted EBITDA low-ends each increased by $5M, and management expects ~60% of full-year EBITDA in H1 (vs ~55% prior-year).
Operational Execution and Technology Progress
Claims auto-adjudication improved from under 15% a year ago to over 60% year-to-date; active investments in claims automation, AI-enabled contract management and risk stratification, and continued capex (~$40M expected) for software and AI to drive future SG&A and MLR improvements.
Clinical Performance and Part D Trends
Clinical teams helped keep inpatient admissions largely within expected ranges after a one-time workflow issue; Part D ran modestly favorable through the first three months and was described as tracking well in Q1.

Alignment Healthcare (ALHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ALHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
0.13 / -
0.07
Apr 30, 2026
2026 (Q1)
<0.01 / 0.05
-0.05200.00% (+0.10)
Feb 26, 2026
2025 (Q4)
-0.15 / -0.05
-0.1668.75% (+0.11)
Oct 30, 2025
2025 (Q3)
-0.08 / 0.02
-0.14114.29% (+0.16)
Jul 30, 2025
2025 (Q2)
-0.07 / 0.07
-0.13153.85% (+0.20)
May 01, 2025
2025 (Q1)
-0.13 / -0.05
-0.2580.00% (+0.20)
Feb 27, 2025
2024 (Q4)
-0.19 / -0.16
-0.2536.00% (+0.09)
Oct 29, 2024
2024 (Q3)
-0.11 / -0.14
-0.1926.32% (+0.05)
Aug 01, 2024
2024 (Q2)
-0.12 / -0.13
-0.1513.33% (+0.02)
May 02, 2024
2024 (Q1)
-0.21 / -0.25
-0.2-25.00% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ALHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2026
$22.54$20.26-10.12%
Feb 26, 2026
$20.42$19.22-5.88%
Oct 30, 2025
$17.12$16.86-1.52%
Jul 30, 2025
$13.00$13.78+6.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alignment Healthcare, Inc. (ALHC) report earnings?
Alignment Healthcare, Inc. (ALHC) is schdueled to report earning on Jul 30, 2026, After Close (Confirmed).
    What is Alignment Healthcare, Inc. (ALHC) earnings time?
    Alignment Healthcare, Inc. (ALHC) earnings time is at Jul 30, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ALHC EPS forecast?
          ALHC EPS forecast for the fiscal quarter 2026 (Q2) is 0.13.